Cargando…

Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes

BACKGROUND: Skin autofluorescence (SAF) is a non-invasive marker of tissue accumulation of advanced glycation endproducts (AGE). Recently, we demonstrated in the general population that elevated SAF levels predict the development of type 2 diabetes (T2D), cardiovascular disease (CVD) and mortality....

Descripción completa

Detalles Bibliográficos
Autores principales:	Boersma, Henderikus E., van Waateringe, Robert P., van der Klauw, Melanie M., Graaff, Reindert, Paterson, Andrew D., Smit, Andries J., Wolffenbuttel, Bruce H. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802158/ https://www.ncbi.nlm.nih.gov/pubmed/33435948 http://dx.doi.org/10.1186/s12902-020-00676-4

Ejemplares similares

Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population
por: van Waateringe, Robert P., et al.
Publicado: (2018)

A non-invasive risk score including skin autofluorescence predicts diabetes risk in the general population
por: Boersma, Henderikus E., et al.
Publicado: (2022)

Lifestyle and clinical determinants of skin autofluorescence in a population‐based cohort study
por: van Waateringe, Robert P., et al.
Publicado: (2016)

Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components
por: van Waateringe, Robert P., et al.
Publicado: (2017)

The association between various smoking behaviors, cotinine biomarkers and skin autofluorescence, a marker for advanced glycation end product accumulation
por: van Waateringe, Robert P., et al.
Publicado: (2017)

Genome-wide association study identifies novel loci associated with skin autofluorescence in individuals without diabetes
por: Vollenbrock, Charlotte E., et al.
Publicado: (2022)

The Association Between Anemia and Skin Autofluorescence, a Marker for Advanced Glycation End Product Accumulation
por: Wouters, Hanneke J.C.M., et al.
Publicado: (2020)

Skin Autofluorescence: A Pronounced Marker of Mortality in Hemodialysis Patients
por: Gerrits, Esther G., et al.
Publicado: (2012)

Skin Autofluorescence Based Decision Tree in Detection of Impaired Glucose Tolerance and Diabetes
por: Smit, Andries J., et al.
Publicado: (2013)

Sex, BMI and age differences in metabolic syndrome: the Dutch Lifelines Cohort Study
por: Slagter, Sandra N, et al.
Publicado: (2017)

Skin autofluorescence assessment of cardiovascular risk in people with severe mental illness
por: Emmerink, Daniëlle, et al.
Publicado: (2018)

Cardiovascular risk management in people with type 1 diabetes: performance using three guidelines
por: Varkevisser, Rita Delphine Maiko, et al.
Publicado: (2022)

Is skin autofluorescence (SAF) representative of dermal advanced glycation endproducts (AGEs) in dark skin? A pilot study
por: Atzeni, Isabella M., et al.
Publicado: (2020)

Thyroid function and metabolic syndrome in the population-based LifeLines cohort study
por: Wolffenbuttel, Bruce H. R., et al.
Publicado: (2017)

Skin Autofluorescence and Mortality in Patients on Peritoneal Dialysis
por: Mácsai, Emília, et al.
Publicado: (2015)

Skin Autofluorescence, as Marker of Accumulation of Advanced Glycation Endproducts and of Cumulative Metabolic Stress, Is Not Increased in Patients with Systemic Sclerosis
por: Hettema, M. E., et al.
Publicado: (2011)

Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease
por: Noordzij, Marjon J., et al.
Publicado: (2011)

Skin Autofluorescence, a Non-Invasive Marker for AGE Accumulation, Is Associated with the Degree of Atherosclerosis
por: den Dekker, Martijn A. M., et al.
Publicado: (2013)

A physically active lifestyle is related to a lower level of skin autofluorescence in a large population with chronic-disease (LifeLines cohort)
por: van de Zande, Saskia Corine, et al.
Publicado: (2022)

Differences in lipid and blood pressure measurements between individuals with type 1 diabetes and the general population: a cross-sectional study
por: Varkevisser, Rita Delphine Maiko, et al.
Publicado: (2023)

Ethnicity and skin autofluorescence-based risk-engines for cardiovascular disease and diabetes mellitus
por: Ahmad, Muhammad Saeed, et al.
Publicado: (2017)

GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence
por: Eny, Karen M., et al.
Publicado: (2014)

The Many Faces of Cobalamin (Vitamin B(12)) Deficiency
por: Wolffenbuttel, Bruce H.R., et al.
Publicado: (2019)

Type 1 diabetes management: Room for improvement
por: Varkevisser, Rita D. M., et al.
Publicado: (2023)

Association Between Peripheral Blood Cell Count Abnormalities and Health-Related Quality of Life in the General Population
por: Wouters, Hanneke J. C. M., et al.
Publicado: (2020)

New Locus for Skin Intrinsic Fluorescence in Type 1 Diabetes Also Associated With Blood and Skin Glycated Proteins
por: Roshandel, Delnaz, et al.
Publicado: (2016)

Skin autofluorescence as a marker of cardiovascular risk in children with chronic kidney disease
por: Makulska, Irena, et al.
Publicado: (2012)

Skin autofluorescence in acute kidney injury
por: Lavielle, Aurelie, et al.
Publicado: (2017)

Health-Related Quality of Life in Relation to Obesity Grade, Type 2 Diabetes, Metabolic Syndrome and Inflammation
por: Slagter, Sandra N., et al.
Publicado: (2015)

Epidemiology of thyroid disorders in the Lifelines Cohort Study (the Netherlands)
por: Wouters, Hanneke J. C. M., et al.
Publicado: (2020)

Small artery elasticity is decreased in patients with systemic lupus erythematosus without increased intima media thickness
por: Nienhuis, Hans LA, et al.
Publicado: (2010)

Skin- and Plasmaautofluorescence in hemodialysis with glucose-free or glucose-containing dialysate
por: Ramsauer, Bernd, et al.
Publicado: (2017)

Non-invasive measurement of skin autofluorescence to evaluate diabetic complications
por: Yamanaka, Mikihiro, et al.
Publicado: (2016)

Skin autofluorescence predicts cancer in subjects with type 2 diabetes
por: Foussard, Ninon, et al.
Publicado: (2021)

Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study
por: Chen, Jinluan, et al.
Publicado: (2023)

Hypothyroidism, comorbidity and health-related quality of life: a population-based study
por: Wouters, Hanneke J C M, et al.
Publicado: (2023)

The association of skin autofluorescence with cardiovascular events and all-cause mortality in persons with chronic kidney disease stage 3: A prospective cohort study
por: Shardlow, Adam, et al.
Publicado: (2020)

Skin autofluorescence, a marker of glucose memory in type 2 diabetes
por: Rigo, Marine, et al.
Publicado: (2020)

Letter to the editor: “Clinical significance of micronutrient supplements in patients with coronavirus disease 2019: A comprehensive systematic review and meta-Analysis”
por: Graaff, Reindert, et al.
Publicado: (2023)

Association of anemia with health-related quality of life and survival: a large population-based cohort study
por: Wouters, Hanneke J.C.M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9hkkv4ermp3ib813j7rhjgl9a9